Oral Abstract Session:
214. Optimizing HIV Treatment
Saturday, October 6, 2018: 10:30 AM-11:45 AM
Room: S 156

Tracks: Adult ID, HIV-STD-TB, Pediatric ID, Trainee

Moderators:  Monica Gandhi, MD, MPH, Division of HIV, Infectious Diseases and Global Medicine, UCSF and Charlene A. Flash, MD MPH, Legacy Community Health and Baylor College of Medicine

10:30 AM
Sustained Viral Suppression with Dolutegravir and Boosted Darunavir Dual Therapy Among Highly Treatment-Experienced Individuals
Kellie Hawkins, MD, MPH; Brian Montague, DO, MS, MPH; Sarah Rowan, MD; Margaret Mclees, MD; Robert Beum, CCP; Steven C. Johnson, MD; Edward Gardner, MD
10:45 AM
Structured Treatment Interruptions in HIV-infected Patients Receiving Antiretroviral Therapy – Implications for Future HIV Cure Trials: a systematic review and meta-analysis
Melanie Stecher, MSc. Public Health; Annika Y. Löhnert, MD; Florian Klein, Univ.-Prof. Dr. med.; Clara Lehmann, PD Dr. med.; Christoph Wyen, MD; Gerd Fätkenheuer, Univ.-Prof. Dr. med.; Janne Vehreschild, Prof. Dr. med.
11:15 AM
Viral Suppression among Participants of the Patient-centered HIV Care Model Project—a Collaboration between Community-based Pharmacists and HIV Clinical Providers
Kathy Byrd, MD, MPH; John Hou, PhD; Patrick Clay, Pharm.D, AAHIVP, CPI, CCTI, FCCP; Tim Bush, MS; Ambrose Delpino, PharmD; Michael Shankle, MPH; Nasima Camp, MPH; Heather Kirkham, PhD, MPH; Ronald Hazen, MPH; Paul Weidle, PharmD MPH
11:30 AM
The Association of Unmet Needs with Subsequent Retention in Care and HIV Suppression Among Hospitalized Patients with HIV Who Are Out of Care
Dima Dandachi, M.D.; Sarah May, M.S.; Jessica Davila, Ph.D.; Jeffrey Cully, Ph.D.; K Rivet Amico, Ph.D.; Michael A. Kallen, Ph.D., M.P.H.; Thomas P. Giordano, M.D., M.P.H., FIDSA

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.